Hologic quarterly results

Discussion in 'Minerva Surgical' started by anonymous, Aug 9, 2019 at 12:09 PM.

  1. anonymous

    anonymous Guest

    Hologic has increased sales their last 2 quarters. What are they doing to do that? Is the party over here at Minerva? Seems like we would be taking share still - since there is so much out there.

    Thoughts?
     

  2. anonymous

    anonymous Guest

     
  3. anonymous

    anonymous Guest

    Hello! Here are the facts. Novasure sales have been down 10 quarters in a row, when compared to the same quarter of the previous year. That’s how we compare quarterly sales on Wall Street. Actual Q2 Novasure sales over the past 4 years as reported by Hologic in their SEC 10Q filings have declined as follows: Q2 2016-$61M, Q2 2017-$57.5M, Q2 2018-$53.5M, and Q2 2019-$48.3M